In recent years, the complexity of p53 signalling has become increasingly apparent with the discovery that p53 is expressed as 12 isoforms whose expression is associated with clinical features and outcomes of human cancers [4–11], and whose cellular activities can modulate cell fate decisions [5, 10, 12–19]. The gene discussed is TP53; the disease is cancer.